IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ORENTI, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.118
NA - Nord America 5.113
AS - Asia 4.763
SA - Sud America 472
AF - Africa 155
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 9
Totale 15.682
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.862
IT - Italia 1.571
SG - Singapore 1.511
CN - Cina 1.390
GB - Regno Unito 1.113
DE - Germania 455
HK - Hong Kong 443
FR - Francia 370
VN - Vietnam 361
BR - Brasile 353
RU - Federazione Russa 353
SE - Svezia 331
IN - India 240
BD - Bangladesh 214
CA - Canada 184
IE - Irlanda 179
NL - Olanda 147
FI - Finlandia 146
ID - Indonesia 103
JP - Giappone 98
KR - Corea 87
DK - Danimarca 85
ES - Italia 69
BE - Belgio 52
TR - Turchia 52
AU - Australia 48
CH - Svizzera 39
ZA - Sudafrica 39
AR - Argentina 35
AT - Austria 35
IQ - Iraq 33
PK - Pakistan 33
MX - Messico 32
UA - Ucraina 30
PL - Polonia 28
UG - Uganda 25
CI - Costa d'Avorio 24
UZ - Uzbekistan 24
PH - Filippine 21
EC - Ecuador 19
EG - Egitto 18
SA - Arabia Saudita 18
MY - Malesia 17
PT - Portogallo 17
TW - Taiwan 16
IL - Israele 15
MA - Marocco 15
PE - Perù 15
CO - Colombia 14
CZ - Repubblica Ceca 14
NP - Nepal 13
HU - Ungheria 12
TH - Thailandia 12
CL - Cile 11
TN - Tunisia 11
GR - Grecia 10
IR - Iran 9
UY - Uruguay 9
LU - Lussemburgo 8
SI - Slovenia 8
VE - Venezuela 8
EU - Europa 7
LB - Libano 7
LT - Lituania 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
XK - ???statistics.table.value.countryCode.XK??? 6
BG - Bulgaria 5
CR - Costa Rica 5
GE - Georgia 5
JM - Giamaica 5
KE - Kenya 5
PY - Paraguay 5
BA - Bosnia-Erzegovina 4
DZ - Algeria 4
NI - Nicaragua 4
NO - Norvegia 4
OM - Oman 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
KH - Cambogia 2
LK - Sri Lanka 2
Totale 15.658
Salva come PNG Salva come JPEG
Città #
Singapore 833
Southend 808
Ashburn 555
Milan 489
Hong Kong 396
Chandler 354
San Jose 311
Dallas 289
Beijing 234
Council Bluffs 227
Fairfield 174
Los Angeles 167
Princeton 158
Dublin 157
Wilmington 153
Frankfurt am Main 147
Seattle 142
Boardman 132
Ho Chi Minh City 116
New York 112
Houston 111
Ann Arbor 104
Santa Clara 103
Rome 100
Hefei 99
Toronto 95
Lauterbourg 93
Woodbridge 88
Helsinki 85
Dearborn 78
Bengaluru 77
Buffalo 76
Jakarta 74
Hanoi 73
Moscow 72
Guangzhou 69
Des Moines 66
Cambridge 61
Nanjing 53
Tokyo 48
Shanghai 45
São Paulo 42
Seoul 38
Hanover 36
Munich 35
Redwood City 35
Amsterdam 33
Cangzhou 33
Tianjin 32
Columbus 31
Jinan 31
Ottawa 31
Phoenix 31
Chicago 30
Mountain View 26
Bologna 25
The Dalles 25
Abidjan 24
Redmond 24
Birmingham 23
Kampala 23
Nuremberg 23
Shenyang 23
Fuzhou 22
Hangzhou 22
Paris 22
Berlin 21
Lappeenranta 21
London 21
Shenzhen 21
Changsha 19
Hebei 18
Zhengzhou 18
Brussels 17
Dong Ket 17
Madrid 17
Naples 17
Pune 17
San Diego 17
Florence 16
Cardiff 15
Cordova 15
Da Nang 15
Falls Church 15
Genoa 15
Haiphong 15
Lima 15
Orem 15
Boston 14
Catania 14
Dhaka 14
Heidelberg 14
Turin 14
Brooklyn 13
Johannesburg 13
Zurich 13
Atlanta 12
Baghdad 12
Bari 12
Bühl 12
Totale 8.878
Salva come PNG Salva come JPEG
Nome #
Valutazione delle dimissioni pianificate: Concordanza tra indice di BRASS e giudizio clinic [The assessment of planned discharges: agreement between BRASS index and clinical judgement] 782
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry Cohort study 464
Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation : the IDEA Study 360
Genetic Polymorphisms of Functional Candidate Genes and Recurrent Acute Otitis Media With or Without Tympanic Membrane Perforation 340
Epidemiology of European adults with cystic fibrosis 338
Pneumococcal colonization in older adults 337
SURVIVAL ANALYSIS AND REGRESSION MODELS IN THE PRESENCE OF COMPETING AND SEMI-COMPETING RISKS 311
Distribution of cystic fibrosis patients not eligible to studied CFTR modulators in Europe 302
Pinpointing outliers in experimental data: the Hat matrix in Anova for fixed and mixed effects models 247
Fever and pain management in childhood : Healthcare providers’ and parents’ adherence to current recommendations 245
Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients 235
Genetic polymorphisms and the development of invasive bacterial infections in children 232
Autoimmunity and cytokine imbalance in inherited epidermolysis bullosa 223
Nasal spray live attenuated influenza vaccine : the first experience in Italy in children and adolescents during the 2020–21 season 221
CHANGES IN FEV1 PERCENT OF PREDICTED OF PEOPLE WITH CYSTIC FIBROSIS IN THE LAST DECADE: USE OF DIFFERENT STATISTICAL METHODS 220
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study 220
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy 219
Hospital discharge : testing the "Blaylock Risk Assessment Screening Score" in a surgical department 214
10-years changes in lung function of cystic fibrosis patients in Europe: different statistical methods at work 203
Impact of endometriosis on obstetric outcome after natural conception: a multicenter Italian study 199
Estimate cause specific survival in soft tissue retroperitoneal sarcomas in the presence of competing risks : relative and net survival 194
Estimating Relapse Free Survival as a Net Probability : Regression Models and Graphical Representation : An Application of a Large Breast Cancer Case Series 185
Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopy 176
The European Cystic Fibrosis Society Patient Registry (ECFSPR) data validation programme: accuracy and consistency of data 175
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe 173
A MULTI-STATE MODEL EVALUATING THE ASSOCIATION OF OXYGEN THERAPY WITH THE COURSE OF CYSTIC FIBROSIS IN EUROPE 172
Differential benefit of docetaxel-based chemotherapy in breast cancer patients according to baseline body mass index 171
Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis : A pragmatic non-randomized trial 170
Detecting outliers and/or leverage points : a robust two-stage procedure with bootstrap cut-off points 168
Tight control in patients with rheumatoid arthritis treated with targeted therapies across the COVID-19 pandemic era 161
Performance of robust regression methods in real-time polymerase chain reaction calibration 159
Antibody response to respiratory syncytial virus infection in children <18 months old 159
Comorbidity burden conditions the prognostic performance of D-dimer in elderly patients with acute pulmonary embolism 159
The burden of air pollution and temperature on Raynaud’s phenomenon secondary to systemic sclerosis 159
Fisiobrì : valutazione del supporto fisioterapico domiciliare alla terapia antibiotica con colistimetato sodico 156
Presenza di outlier nei saggi biologici con PCR real-time: L1-norm (LAD) or L2-norm (OLS)? 154
Evolution of disease in people with cystic fibrosis carrying 2 nonsense mutations in Europe 153
Uniphasic blanching of the fingers, abnormal capillaroscopy in nonsymptomatic digits, and autoantibodies: expanding options to increase the level of suspicion of connective tissue diseases beyond the classification of Raynaud's Phenomenon 153
Survival functions in the presence of several events and competing risks : estimation and interpretation Beyond Kaplan-Meier 151
Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based study 148
Enhanced liver fibrosis test : a further step toward depiction of fibrotic process in very early diagnosis of systemic sclerosis 147
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 147
Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage 146
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry 146
Trauma e discontinuità temporale nei minori vittime di disastri naturali : Il Test de trois dessins : Avant, pendant et avenir 145
The parameter τ and its role in least absolute deviation regression 143
Correction to: Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients 143
Prognostic value of D-dimer in elderly patients with Pulmonary Embolism 143
Prospective evaluation of the aetiology of acute otitis media with spontaneous tympanic membrane perforation 141
The European Cystic Fibrosis Society Patient Registry’s Data Quality programme 141
From ordinary to generalized least squares : a worked example 140
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 140
Empirical Approach to Investigate Raynaud's Phenomenon : the Pearl Study : AB1085  139
Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy 139
Fibrosis biomarkers in isolated Raynaud's phenomenon : too little, too soon? 137
Lung transplantation and mortality in patients with cystic fibrosis under oxygen therapy 134
Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis: a single centre pragmatic non-randomised trial 133
Short and long-term mortality in elderly patients with suspected not confirmed pulmonary embolism 132
Pinpointing outliers and influential cases in regression analysis : a robust method at work 131
Cystic fibrosis in Europe: improved lung function & longevity: reasons for cautious optimism, but challenges remain 130
A pseudo-values regression model for non-fatal event free survival in the presence of semi-competing risks 128
Robust Regression as a Sensible Alternative to the Weighted Ordinary Least Squares Regression in case of Heteroskedasticity. A Tutorial 127
Enhanced liver fibrosis test: a further step toward depiction of fibrotic process in very early diagnosis of systemic sclerosis 127
Acute effect of iloprost on peripheral circulation as assessed by videocapillaroscopy and 22-mhz power doppler ultrasonography 126
Performance of robust regression methods in real-time polymerase chain reaction calibration 125
How early starts increased collagen synthesis in systemic sclerosis? 125
Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients : 15-Year results of trial and out-trial patients 122
A performance counterexample of Billor-Chatterjee-Hadi procedure and an improvement proposal for robust regression 122
Factors associated with sustained Pseudomonas aeruginosa infection following elexacaftor/tezacaftor/ivacaftor treatment: Real-world data from the European cystic fibrosis society patient registry 121
Epidemiology of European adults with Cystic Fibrosis 119
Prevalence, trends and outcomes of long-term inhaled antibiotic treatment in people with cystic fibrosis without chronic Pseudomonas aeruginosa infection – A European cystic fibrosis patient registry data analysis 115
Robust regression analysis : a useful two stage procedure 113
Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation 113
Incidence of SARS-CoV-2 and risk factors for severe outcomes in people with cystic fibrosis in Europe 111
Acute pulmonary embolism in patients presenting pulmonary deterioration after hospitalization for non-critical COVID-19 108
Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis 106
Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry 104
Total ankle replacement: is pre-operative varus deformity a predictor of poor survival rate and clinical and radiological outcomes? 103
Predictors of medium- and long-term mortality in elderly patients with acute pulmonary embolism 102
A reaction to a challenging example in multiple regression analysis 100
Pseudo-values regression models in the presence of semi-competing risks 100
A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA 99
Pianificare la dimissione dei soggetti adulti ricoverati nel dipartimento chirurgico: uno studio osservazionale 99
Comorbidities and prognostic performance of D-Dimer in acute pulmonary embolism elderly patients 98
Home physiotherapists assisting follow-up treatment in cystic fibrosis : a multicenter observational study 96
Variability in Disease Severity Among Cystic Fibrosis Patients carrying Residual Function Variants: Data from the European Cystic Fibrosis Society Patient Registry 95
Serum levels of testosterone and SHBG in association with body mass index improve the predictive capability of consolidate tumor biomarkers in pre- and postmenopausal breast cancer patients 94
History of digital ulcers in patients with systemic sclerosis is associated with peripheral vasculopathy as assessed by videocapillaroscopy and 22-mhz power doppler ultrasonography 93
Comorbidity assessment as predictor of short and long-term mortality in elderly patients with hemodynamically stable acute pulmonary embolism 93
Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry 93
How much temperature can truly impact on Raynaud’s phenomenon secondary to systemic sclerosis? 91
Methicillin-Resistant Staphylococcus Aureus and Pulmonary Outcome in People with Cystic Fibrosis: A European Cystic Fibrosis Patient Registry Data Analysis 90
Esimating relapse free survival as a net probability: regression models and graphical representation 89
Regression models in the presence of semi-competing risks 87
How much temperature can truly impact on raynaud's phenomenon secondary to systemic sclerosis? 87
Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management 87
Sustaining adherence to colistimethate sodium (Colobreathe®) through a physiotherapist-supervised program (PsP) at home 83
Role of nailfold videocapillaroscopy and 22-MHZ Doppler ultrasound in the assessment of systemic sclerosis-related digital vasculopathy 82
Disease severity of people with cystic fibrosis carrying residual function mutations: Data from the ECFS Patient Registry 81
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children 81
Totale 16.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.511
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 0 0 0 0 0 82 76
2021/20221.379 60 84 63 87 102 135 104 82 200 107 112 243
2022/20231.531 182 138 152 160 138 256 47 117 164 29 105 43
2023/20241.477 55 65 107 127 273 148 78 114 55 96 159 200
2024/20252.879 176 283 98 268 226 160 97 274 175 225 311 586
2025/20265.804 611 396 563 438 575 401 755 342 660 469 594 0
Totale 16.455